跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
沃克 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Vonoprazan Fumarate Tablets
Approved
化学药品
Vonoprazan Fumarate Tablets
TAKEDA PHARMACEUTICAL COMPANY LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Dec 18, 2019
Approval ID
7uciyh8dR7T
Company
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Type
化学药品
Approval Details
Approval Id
7uciyh8dR7T
Approval Number
H20190065
Generic Name
富马酸伏诺拉生片
Generic Name En
Vonoprazan Fumarate Tablets
Trade Name
沃克
Drug Type
化学药品
Dosage Form
片剂
Strength
按C₁₇H₁₆FN₃O₂S计20mg
Reg Date
2019-12-18
Expired Date
2024-12-17
Company Name
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Company Address
1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645, Japan
Production Company Name
takeda pharmaceutical company limited, hikari plant
Production Company Address
4720, Takeda, Mitsui, Hikari, Yamaguchi 743-8502, Japan
Company Detail Path
/organization/takeda-pharmaceutical-company-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 18, 2019
Approval ID
7uciyh8dR7T
Type
化学药品
Back to NMPA Approvals